Last reviewed · How we verify
NCT04662333
Adjunctive Benefit of Xenograft Plus a Membrane During Sinus Crestal Approach
NA trial testing Transcrestal approach for sinus lift in Edentulous Jaw in 36 participants. Status unknown.
1 March 2023
Quick facts
| Lead sponsor | University of Siena |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 36 |
| Start date | 1 October 2020 |
| Primary completion | 1 March 2023 |
| Estimated completion | 1 March 2023 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Transcrestal approach for sinus lift
- Xenograft application
Conditions studied
- Edentulous Jaw — all drugs for Edentulous Jaw →
Sponsor
University of Siena
Who can join
18 and older, any sex, with Edentulous Jaw. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Patients in need for implant-supported restoration in maxillary posterior sites with insufficient residual bone height will be randomly allocated to two different arms. Crestal sinus lift with simultaneous implant placement will be performed in both groups. Control group: crestal sinus lift with no adjunctive biomaterial; Test group: crestal sinus lift associated with xenogenic bone graft and collagen membrane; Six months after implant placement, implants will be loaded with definitive screw-retained prostheses. Six months later, patients will be recalled for clinical and radiographic assessment.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04662333
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Edentulous Jaw
Currently open trials in the same condition.
- NCT07065487 — Accuracy of Standard and Geometric Pattern-Assisted Digital Scanning for Full-Arch Implant Prosthesis Frameworks · NA · recruiting
- NCT07177521 — Primary Stability and Peri-implant Outcomes of Short Implants in Post-extraction Single-tooth Sites · NA · recruiting
- NCT05924386 — Marginal Bone Changes in Fixed All-on-Four Mandibular Prosthesis Using OT Bridge Attachment System · NA · recruiting
- NCT06678945 — Using Two Different Attachments in Mandibular Implant Overdenture Cases in Order to Retention and Patient Satisfaction · NA · active not recruiting
- NCT06080633 — Facial Prediction Technology for Edentulous Patients · recruiting
Other University of Siena trials
Trials by the same sponsor.
- NCT07053865 — Electromyographic Assessment of Sleep Bruxism in Patients With Stage III and IV Periodontitis · completed
- NCT07053878 — Changes in Bruxism Activity After Periodontal Treatment in Patients With Periodontitis · NA · completed
- NCT07018284 — Postoperative Pain Evaluation After Obturation With Different Sealers · NA · recruiting
- NCT07019298 — Success of Endodontic Treatment With Different Obturation Techniques and Sealer Cements · NA · recruiting
- NCT06923748 — Comparison of Two Interdental Devices for Peri-Implant Plaque Control · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04662333 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Siena
- Last refreshed: 10 December 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04662333.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing